HYDROchlorothiazide to PROTECT Polycystic Kidney Disease Patients and Improve Their Quality of Life
Condition(s):ADPKDLast Updated:September 29, 2023Not yet recruiting
Hide Studies Not Open or Pending
Condition(s):ADPKDLast Updated:September 29, 2023Not yet recruiting
Condition(s):Renal InsufficiencyLast Updated:November 19, 2012Completed
Condition(s):Chronic Kidney DiseaseLast Updated:March 5, 2024Completed
Condition(s):End Stage Renal DiseaseLast Updated:December 1, 2023Recruiting
Condition(s):Chronic Kidney Disease; Hyperuricemia; Abnormal Renal FunctionLast Updated:July 24, 2019Completed
Condition(s):Fibrosis; Chronic Kidney DiseaseLast Updated:April 3, 2015Completed
Condition(s):Renal Insufficiency; Hepatic Insufficiency; ImmunosuppressionLast Updated:July 7, 2023Completed
Condition(s):Chronic Kidney DiseaseLast Updated:July 22, 2011Completed
Condition(s):Polycystic Kidney, Type 1 Autosomal Dominant Disease; Polycystic Kidney, Type 2 Autosomal Dominant DiseaseLast Updated:October 31, 2018Unknown status
Condition(s):Kidney Disease, ChronicLast Updated:October 2, 2023Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.